Precigen (PGEN)
(Real Time Quote from BATS)
$1.36 USD
+0.01 (0.74%)
Updated May 14, 2024 03:55 PM ET
After-Market: $1.36 0.00 (0.00%) 4:12 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PGEN 1.36 +0.01(0.74%)
Will PGEN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for PGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PGEN
Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
Should You Buy Precigen, Inc. (PGEN) After Golden Cross?
PGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Tops Revenue Estimates
Fulcrum Therapeutics, Inc. (FULC) Reports Q2 Loss, Lags Revenue Estimates
Paratek Pharmaceuticals (PRTK) Reports Q1 Loss, Misses Revenue Estimates
Other News for PGEN
Precigen Reports First Quarter 2024 Financial Results and Business Updates
Precigen GAAP EPS of -$0.10 misses by $0.01, revenue of $1.07M misses by $0.41M
Precigen reports Q1 EPS (10c), consensus (9c)
Precigen Q1 2024 Earnings Preview
Notable earnings after Tuesday's close